Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics


Arena Pharmaceuticals, Inc. (ARNA)

Today's Latest Price: $76.33 USD

1.65 (2.21%)

Updated Jan 28 11:14am

Add ARNA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 488 in Biotech

See all "A" rated Strong Buy stocks

ARNA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ARNA is 0 -- better than merely 8.41% of US stocks.
  • ARNA's price/sales ratio is 1,322.68; that's higher than the P/S ratio of 99.31% of US stocks.
  • As for revenue growth, note that ARNA's revenue has grown -99.6% over the past 12 months; that beats the revenue growth of merely 0.53% of US companies in our set.
  • Stocks that are quantitatively similar to ARNA, based on their financial statements, market capitalization, and price volatility, are CRNX, MRSN, GERN, CBMG, and INO.
  • Visit ARNA's SEC page to see the company's official filings. To visit the company's web site, go to www.arenapharm.com.

ARNA Stock Price Chart Interactive Chart >

Price chart for ARNA

ARNA Price/Volume Stats

Current price $76.33 52-week high $90.19
Prev. close $74.68 52-week low $32.95
Day low $75.00 Volume 122,294
Day high $77.05 Avg. volume 460,065
50-day MA $72.53 Dividend yield N/A
200-day MA $67.55 Market Cap 4.44B

Arena Pharmaceuticals, Inc. (ARNA) Company Bio


Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.


ARNA Latest News Stream


Event/Time News Detail
Loading, please wait...

ARNA Latest Social Stream


Loading social stream, please wait...

View Full ARNA Social Stream

Latest ARNA News From Around the Web

Below are the latest news stories about Arena Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARNA as an investment opportunity.

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on January 15, 2021, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to purchase an aggregate of 16,950 shares of its common stock and 3,470 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of January 15, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).

Yahoo | January 22, 2021

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript)

Arena Pharmaceuticals, Inc. (ARNA) 39th Annual J.P. Morgan Healthcare Conference January 13, 2021 01:00 PM ET Company Participants Amit Munshi - President and Chief Executive Officer Conference Call Participants Jess Fye - JP Morgan Presentation Jess Fye Good morning everyone. My name is Jess Fye. I'm one of the senior...

SA Transcripts on Seeking Alpha | January 13, 2021

Arena Pharmaceuticals: Humira LOE Coming At Right Time For Potential Blockbuster Etrasimod

Investment Thesis Arena Pharmaceuticals (ARNA) stock is up 78% in 2020, and the developer of G protein-coupled receptors ("GCPRs") ought to have an exciting year in store, with multiple data readouts due in relation to its lead asset Etrasimod - an oral Sphingosine-1-phosphate ("S1P") Receptor Modulator indicated for multiple immune-mediated...

Edmund Ingham on Seeking Alpha | December 29, 2020

Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 10:00 AM ET.

Yahoo | December 22, 2020

Anti-obesity Drugs Market: The Next Big Innovation in Machinery Industry 2020||Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche

The global Anti-obesity Drugs market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future

OpenPR | December 15, 2020

Read More 'ARNA' Stories Here

ARNA Price Returns

1-mo -0.20%
3-mo -10.95%
6-mo 24.34%
1-year 71.76%
3-year 108.44%
5-year 405.50%
YTD -0.65%
2020 69.15%
2019 16.61%
2018 14.66%
2017 139.23%
2016 -25.26%

Continue Researching ARNA

Want to see what other sources are saying about Arena Pharmaceuticals Inc's financials and stock price? Try the links below:

Arena Pharmaceuticals Inc (ARNA) Stock Price | Nasdaq
Arena Pharmaceuticals Inc (ARNA) Stock Quote, History and News - Yahoo Finance
Arena Pharmaceuticals Inc (ARNA) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9613 seconds.